November 20, 2024

TROPION-Lung01 Update: Dato-DXd Shows Activity in Previously Treated Advanced Nonsquamous NSCLC

The novel trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd) vs docetaxel conferred a numerical improvement in overall survival in previously...

The ASCO Post

November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

New Hope for Hand Function in RA?

Chinese mind-body exercise Yijinjing improved hand function, strength, and flexibility in rheumatoid arthritis patients without exacerbating inflammation

Conexiant

November 20, 2024

ASH to Present 2024 Honorific Awards at Annual Meeting

The American Society of Hematology (ASH) will recognize exemplary hematologists who have made significant contributions to the field with several honorific awards at the 2024 ASH Annual Meeting and Ex...

The ASCO Post

November 20, 2024

4.0 mg/L: The Key to RA Control?

Adalimumab trough levels ≥4.0 mg/L were linked to nearly fourfold higher odds of remission in RA patients, highlighting a potential target for therapeutic drug monitoring.

Conexiant

November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 20, 2024

Exploring Issues in Oncofertility

An expert panel discussed the importance of oncofertility in the delivery of high-quality cancer care at the FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug D...

The ASCO Post

November 20, 2024

Oral Minoxidil Dosing Set by Experts

International hair loss experts reached consensus on low-dose oral minoxidil for alopecia in adults and adolescents, but not children under 12, in a modified Delphi study.

Conexiant